Completed OBSERVATIONAL NCT01428180

Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants

Changes of Cerebral Tissue Oxygen Saturation During Treatment of Patent Ductus Arteriosus in Neonates

Sponsor: University of Ulm

Conditions Patent Ductus Arteriosus Prematurity of Fetus

Interventions Ibuprofen Indomethacin Surgical Ligation

Updated 6 times since 2017 Last updated: Apr 5, 2016 Started: Apr 30, 2011 Primary completion: Oct 31, 2012 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Patent Ductus Arteriosus and Prematurity of Fetus and is currently completed. University of Ulm leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Ulm

Data source: University of Ulm

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ulm, Germany